Abbott, BioGenex Extend Assay Deal | GenomeWeb

NEW YORK (GenomeWeb News) – BioGenex today said that Abbott has extended a technology co-development and distribution agreement covering marketing of the firm's Xmatrx platform for the automation of Abbott's fluorescence in situ hybridization (FISH) product line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.